Innoviva (INVA) Net Cash Flow (2010 - 2026)
Innoviva (INVA) posted Net Cash Flow of $52.1 million for Q1 2026, down 69.6% on a QoQ basis from $171.5 million in Q3 2025, and up 269.13% year-over-year from $14.1 million in Q1 2025.
Innoviva (INVA) Net Cash Flow (2010 - 2026) Analysis & Trends
Innoviva's Net Cash Flow history runs 17 years deep, the most recent figure standing at $52.1 million for Q1 2026.
- Quarterly Net Cash Flow rose 269.13% year-over-year to $52.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $302.1 million (up 152.01% YoY) and the FY2025 annual result came in at $246.0 million, up 120.7% from the prior year.
- Net Cash Flow was $52.1 million for Q1 2026 at Innoviva, down from $171.5 million in the prior quarter.
- Across five years, Net Cash Flow topped out at $171.5 million in Q3 2025 and bottomed at -$147.0 million in Q1 2023.
- A 5-year average of $27.6 million and a median of $38.6 million in 2024 frame the typical range for Net Cash Flow.
- Annual changes were most pronounced in 2023 — Net Cash Flow slumped 1062.23% — and 2026, when it jumped 269.13%.
- Innoviva's Net Cash Flow stood at $99.3 million in 2022, then plunged by 211.83% to -$111.1 million in 2023, then jumped by 160.44% to $67.1 million in 2024, then surged by 155.6% to $171.5 million in 2025, then tumbled by 69.6% to $52.1 million in 2026.
- Business Quant data shows INVA's Net Cash Flow at $52.1 million in Q1 2026, $171.5 million in Q3 2025, and $78.4 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | 10.56 Mn |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -2.44 Mn |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 224.46 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 457.40 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -152.20 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 57.19 Mn |
| 10 | Innoviva | 1.58 Bn | 979.49 Mn | 75.83 Mn | 52.14 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 52.14 Mn |
| Mar 31, 2026 | 52.14 Mn |
| Sep 30, 2025 | 171.55 Mn |
| Sep 30, 2025 | 171.55 Mn |
| Jun 30, 2025 | 78.44 Mn |
| Jun 30, 2025 | 78.44 Mn |
| Mar 31, 2025 | 14.13 Mn |
| Mar 31, 2025 | 14.13 Mn |
| Sep 30, 2024 | 67.12 Mn |
| Sep 30, 2024 | 67.12 Mn |
| Jun 30, 2024 | 38.65 Mn |
| Jun 30, 2024 | 38.65 Mn |
| Mar 31, 2024 | -15.16 Mn |
| Mar 31, 2024 | -15.16 Mn |
| Sep 30, 2023 | -111.05 Mn |
| Sep 30, 2023 | -111.05 Mn |
| Jun 30, 2023 | 28.98 Mn |
| Jun 30, 2023 | 28.98 Mn |
| Mar 31, 2023 | -147.00 Mn |
| Mar 31, 2023 | -147.00 Mn |